nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—Voacamine—Vinblastine—kidney cancer	0.384	0.5	CrCrCtD
Rescinnamine—Voacamine—Vincristine—kidney cancer	0.384	0.5	CrCrCtD
Rescinnamine—ACE—renal artery—kidney cancer	0.0315	0.493	CbGeAlD
Rescinnamine—ACE—nephron—kidney cancer	0.011	0.172	CbGeAlD
Rescinnamine—ACE—urine—kidney cancer	0.00883	0.138	CbGeAlD
Rescinnamine—ACE—nephron tubule—kidney cancer	0.00238	0.0372	CbGeAlD
Rescinnamine—ACE—renal system—kidney cancer	0.00216	0.0338	CbGeAlD
Rescinnamine—ACE—kidney—kidney cancer	0.00209	0.0327	CbGeAlD
Rescinnamine—ACE—cortex of kidney—kidney cancer	0.00203	0.0319	CbGeAlD
Rescinnamine—ACE—gonad—kidney cancer	0.00194	0.0303	CbGeAlD
Rescinnamine—ACE—cardiac atrium—kidney cancer	0.00193	0.0303	CbGeAlD
Rescinnamine—Voacamine—ABCB1—kidney cancer	0.000819	0.648	CrCbGaD
Rescinnamine—ACE—Metabolism of Angiotensinogen to Angiotensins—MME—kidney cancer	0.000543	0.186	CbGpPWpGaD
Rescinnamine—Reserpine—ABCB1—kidney cancer	0.000446	0.353	CrCbGaD
Rescinnamine—ACE—Metabolism of Angiotensinogen to Angiotensins—CTSD—kidney cancer	0.000394	0.135	CbGpPWpGaD
Rescinnamine—Influenza—Paclitaxel—kidney cancer	0.00032	0.00196	CcSEcCtD
Rescinnamine—Dermatitis bullous—Capecitabine—kidney cancer	0.000318	0.00195	CcSEcCtD
Rescinnamine—Erythema—Dactinomycin—kidney cancer	0.000315	0.00193	CcSEcCtD
Rescinnamine—Oedema—Erlotinib—kidney cancer	0.000313	0.00192	CcSEcCtD
Rescinnamine—Infection—Erlotinib—kidney cancer	0.000311	0.00191	CcSEcCtD
Rescinnamine—Pruritus—Temsirolimus—kidney cancer	0.000309	0.00189	CcSEcCtD
Rescinnamine—Bronchitis—Paclitaxel—kidney cancer	0.000308	0.00189	CcSEcCtD
Rescinnamine—Rhinitis—Gemcitabine—kidney cancer	0.000307	0.00188	CcSEcCtD
Rescinnamine—Pharyngitis—Gemcitabine—kidney cancer	0.000304	0.00186	CcSEcCtD
Rescinnamine—Cough—Sorafenib—kidney cancer	0.000301	0.00185	CcSEcCtD
Rescinnamine—Skin discolouration—Doxorubicin—kidney cancer	0.000299	0.00183	CcSEcCtD
Rescinnamine—Hypertension—Sorafenib—kidney cancer	0.000298	0.00183	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000296	0.00181	CcSEcCtD
Rescinnamine—Cough increased—Doxorubicin—kidney cancer	0.000295	0.00181	CcSEcCtD
Rescinnamine—Myalgia—Sorafenib—kidney cancer	0.000294	0.0018	CcSEcCtD
Rescinnamine—Insomnia—Everolimus—kidney cancer	0.000294	0.0018	CcSEcCtD
Rescinnamine—Lacrimation increased—Doxorubicin—kidney cancer	0.000293	0.0018	CcSEcCtD
Rescinnamine—Paraesthesia—Vinblastine—kidney cancer	0.000293	0.00179	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Paclitaxel—kidney cancer	0.000293	0.00179	CcSEcCtD
Rescinnamine—Paraesthesia—Everolimus—kidney cancer	0.000292	0.00179	CcSEcCtD
Rescinnamine—Pruritus—Pazopanib—kidney cancer	0.000291	0.00178	CcSEcCtD
Rescinnamine—Cough—Sunitinib—kidney cancer	0.00029	0.00178	CcSEcCtD
Rescinnamine—Dizziness—Temsirolimus—kidney cancer	0.000289	0.00177	CcSEcCtD
Rescinnamine—Hypertension—Sunitinib—kidney cancer	0.000287	0.00176	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000286	0.00175	CcSEcCtD
Rescinnamine—Insomnia—Erlotinib—kidney cancer	0.000283	0.00174	CcSEcCtD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—ALDH1A1—kidney cancer	0.000283	0.0972	CbGpPWpGaD
Rescinnamine—Myalgia—Sunitinib—kidney cancer	0.000283	0.00173	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Paclitaxel—kidney cancer	0.000282	0.00173	CcSEcCtD
Rescinnamine—Myocardial infarction—Paclitaxel—kidney cancer	0.00028	0.00172	CcSEcCtD
Rescinnamine—Infection—Sorafenib—kidney cancer	0.00028	0.00172	CcSEcCtD
Rescinnamine—Pain—Vinblastine—kidney cancer	0.000279	0.00171	CcSEcCtD
Rescinnamine—Constipation—Vinblastine—kidney cancer	0.000279	0.00171	CcSEcCtD
Rescinnamine—Conjunctivitis—Paclitaxel—kidney cancer	0.000278	0.0017	CcSEcCtD
Rescinnamine—Urinary tract infection—Paclitaxel—kidney cancer	0.000278	0.0017	CcSEcCtD
Rescinnamine—Pain—Everolimus—kidney cancer	0.000278	0.0017	CcSEcCtD
Rescinnamine—Constipation—Everolimus—kidney cancer	0.000278	0.0017	CcSEcCtD
Rescinnamine—Rash—Temsirolimus—kidney cancer	0.000275	0.00169	CcSEcCtD
Rescinnamine—Dermatitis—Temsirolimus—kidney cancer	0.000275	0.00169	CcSEcCtD
Rescinnamine—Headache—Temsirolimus—kidney cancer	0.000274	0.00168	CcSEcCtD
Rescinnamine—Dizziness—Pazopanib—kidney cancer	0.000272	0.00167	CcSEcCtD
Rescinnamine—Back pain—Vincristine—kidney cancer	0.000272	0.00167	CcSEcCtD
Rescinnamine—Oedema—Sunitinib—kidney cancer	0.000271	0.00166	CcSEcCtD
Rescinnamine—Vaginal inflammation—Doxorubicin—kidney cancer	0.00027	0.00166	CcSEcCtD
Rescinnamine—Infection—Sunitinib—kidney cancer	0.00027	0.00165	CcSEcCtD
Rescinnamine—Gastritis—Capecitabine—kidney cancer	0.000269	0.00165	CcSEcCtD
Rescinnamine—Sinusitis—Paclitaxel—kidney cancer	0.000268	0.00164	CcSEcCtD
Rescinnamine—Pain—Erlotinib—kidney cancer	0.000268	0.00164	CcSEcCtD
Rescinnamine—Constipation—Erlotinib—kidney cancer	0.000268	0.00164	CcSEcCtD
Rescinnamine—Myalgia—Dactinomycin—kidney cancer	0.000268	0.00164	CcSEcCtD
Rescinnamine—Dermatitis contact—Doxorubicin—kidney cancer	0.000267	0.00164	CcSEcCtD
Rescinnamine—Erythema—Gemcitabine—kidney cancer	0.000267	0.00163	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Vinblastine—kidney cancer	0.000267	0.00163	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Everolimus—kidney cancer	0.000266	0.00163	CcSEcCtD
Rescinnamine—Discomfort—Dactinomycin—kidney cancer	0.000265	0.00162	CcSEcCtD
Rescinnamine—Influenza—Capecitabine—kidney cancer	0.000263	0.00161	CcSEcCtD
Rescinnamine—Rash—Pazopanib—kidney cancer	0.000259	0.00159	CcSEcCtD
Rescinnamine—Nausea—Temsirolimus—kidney cancer	0.000259	0.00159	CcSEcCtD
Rescinnamine—Dermatitis—Pazopanib—kidney cancer	0.000259	0.00159	CcSEcCtD
Rescinnamine—Back pain—Gemcitabine—kidney cancer	0.000258	0.00158	CcSEcCtD
Rescinnamine—Abdominal pain—Vinblastine—kidney cancer	0.000258	0.00158	CcSEcCtD
Rescinnamine—Headache—Pazopanib—kidney cancer	0.000258	0.00158	CcSEcCtD
Rescinnamine—Rhinitis—Paclitaxel—kidney cancer	0.000257	0.00158	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000257	0.00157	CcSEcCtD
Rescinnamine—Oedema—Dactinomycin—kidney cancer	0.000257	0.00157	CcSEcCtD
Rescinnamine—Abdominal pain—Everolimus—kidney cancer	0.000257	0.00157	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Erlotinib—kidney cancer	0.000256	0.00157	CcSEcCtD
Rescinnamine—Angina pectoris—Capecitabine—kidney cancer	0.000256	0.00157	CcSEcCtD
Rescinnamine—Hypoaesthesia—Paclitaxel—kidney cancer	0.000255	0.00156	CcSEcCtD
Rescinnamine—Infection—Dactinomycin—kidney cancer	0.000255	0.00156	CcSEcCtD
Rescinnamine—Vaginal infection—Doxorubicin—kidney cancer	0.000255	0.00156	CcSEcCtD
Rescinnamine—Pharyngitis—Paclitaxel—kidney cancer	0.000255	0.00156	CcSEcCtD
Rescinnamine—Bronchitis—Capecitabine—kidney cancer	0.000253	0.00155	CcSEcCtD
Rescinnamine—Abdominal pain—Erlotinib—kidney cancer	0.000248	0.00152	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000247	0.00151	CcSEcCtD
Rescinnamine—Insomnia—Sunitinib—kidney cancer	0.000245	0.0015	CcSEcCtD
Rescinnamine—Nausea—Pazopanib—kidney cancer	0.000244	0.0015	CcSEcCtD
Rescinnamine—Paraesthesia—Sunitinib—kidney cancer	0.000244	0.00149	CcSEcCtD
Rescinnamine—Hypertension—Vincristine—kidney cancer	0.000243	0.00149	CcSEcCtD
Rescinnamine—Pain—Sorafenib—kidney cancer	0.000241	0.00148	CcSEcCtD
Rescinnamine—Constipation—Sorafenib—kidney cancer	0.000241	0.00148	CcSEcCtD
Rescinnamine—Hypersensitivity—Vinblastine—kidney cancer	0.00024	0.00147	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Capecitabine—kidney cancer	0.00024	0.00147	CcSEcCtD
Rescinnamine—Myalgia—Vincristine—kidney cancer	0.000239	0.00147	CcSEcCtD
Rescinnamine—Hypersensitivity—Everolimus—kidney cancer	0.000239	0.00147	CcSEcCtD
Rescinnamine—Hypertonia—Doxorubicin—kidney cancer	0.000237	0.00145	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000234	0.00143	CcSEcCtD
Rescinnamine—Cough—Gemcitabine—kidney cancer	0.000233	0.00143	CcSEcCtD
Rescinnamine—Constipation—Sunitinib—kidney cancer	0.000232	0.00142	CcSEcCtD
Rescinnamine—Pain—Sunitinib—kidney cancer	0.000232	0.00142	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Capecitabine—kidney cancer	0.000231	0.00142	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000231	0.00141	CcSEcCtD
Rescinnamine—Hypertension—Gemcitabine—kidney cancer	0.00023	0.00141	CcSEcCtD
Rescinnamine—Myocardial infarction—Capecitabine—kidney cancer	0.00023	0.00141	CcSEcCtD
Rescinnamine—Pruritus—Everolimus—kidney cancer	0.00023	0.00141	CcSEcCtD
Rescinnamine—Oedema—Vincristine—kidney cancer	0.000229	0.00141	CcSEcCtD
Rescinnamine—Infection—Vincristine—kidney cancer	0.000228	0.0014	CcSEcCtD
Rescinnamine—Conjunctivitis—Capecitabine—kidney cancer	0.000228	0.0014	CcSEcCtD
Rescinnamine—Urinary tract infection—Capecitabine—kidney cancer	0.000228	0.0014	CcSEcCtD
Rescinnamine—Myalgia—Gemcitabine—kidney cancer	0.000227	0.00139	CcSEcCtD
Rescinnamine—Discomfort—Gemcitabine—kidney cancer	0.000224	0.00137	CcSEcCtD
Rescinnamine—Urticaria—Sorafenib—kidney cancer	0.000224	0.00137	CcSEcCtD
Rescinnamine—Erythema—Paclitaxel—kidney cancer	0.000223	0.00137	CcSEcCtD
Rescinnamine—Abdominal pain—Sorafenib—kidney cancer	0.000223	0.00137	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000222	0.00136	CcSEcCtD
Rescinnamine—Pruritus—Erlotinib—kidney cancer	0.000222	0.00136	CcSEcCtD
Rescinnamine—Pain—Dactinomycin—kidney cancer	0.00022	0.00135	CcSEcCtD
Rescinnamine—Dysgeusia—Paclitaxel—kidney cancer	0.000219	0.00134	CcSEcCtD
Rescinnamine—Oedema—Gemcitabine—kidney cancer	0.000218	0.00133	CcSEcCtD
Rescinnamine—Infection—Gemcitabine—kidney cancer	0.000216	0.00133	CcSEcCtD
Rescinnamine—Back pain—Paclitaxel—kidney cancer	0.000216	0.00132	CcSEcCtD
Rescinnamine—Dizziness—Vinblastine—kidney cancer	0.000216	0.00132	CcSEcCtD
Rescinnamine—Dizziness—Everolimus—kidney cancer	0.000215	0.00132	CcSEcCtD
Rescinnamine—Abdominal pain—Sunitinib—kidney cancer	0.000214	0.00131	CcSEcCtD
Rescinnamine—Rhinitis—Capecitabine—kidney cancer	0.000211	0.00129	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00021	0.00129	CcSEcCtD
Rescinnamine—Hypoaesthesia—Capecitabine—kidney cancer	0.000209	0.00128	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000209	0.00128	CcSEcCtD
Rescinnamine—Pharyngitis—Capecitabine—kidney cancer	0.000209	0.00128	CcSEcCtD
Rescinnamine—Hypersensitivity—Sorafenib—kidney cancer	0.000208	0.00127	CcSEcCtD
Rescinnamine—Insomnia—Vincristine—kidney cancer	0.000208	0.00127	CcSEcCtD
Rescinnamine—Dizziness—Erlotinib—kidney cancer	0.000207	0.00127	CcSEcCtD
Rescinnamine—Paraesthesia—Vincristine—kidney cancer	0.000206	0.00126	CcSEcCtD
Rescinnamine—Dermatitis bullous—Doxorubicin—kidney cancer	0.000205	0.00126	CcSEcCtD
Rescinnamine—Rash—Everolimus—kidney cancer	0.000205	0.00126	CcSEcCtD
Rescinnamine—Dermatitis—Everolimus—kidney cancer	0.000205	0.00125	CcSEcCtD
Rescinnamine—Headache—Vinblastine—kidney cancer	0.000204	0.00125	CcSEcCtD
Rescinnamine—Headache—Everolimus—kidney cancer	0.000203	0.00125	CcSEcCtD
Rescinnamine—Abdominal pain—Dactinomycin—kidney cancer	0.000203	0.00124	CcSEcCtD
Rescinnamine—Hypersensitivity—Sunitinib—kidney cancer	0.0002	0.00122	CcSEcCtD
Rescinnamine—Pruritus—Sorafenib—kidney cancer	0.000199	0.00122	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000198	0.00122	CcSEcCtD
Rescinnamine—Rash—Erlotinib—kidney cancer	0.000198	0.00121	CcSEcCtD
Rescinnamine—Dermatitis—Erlotinib—kidney cancer	0.000197	0.00121	CcSEcCtD
Rescinnamine—Insomnia—Gemcitabine—kidney cancer	0.000197	0.00121	CcSEcCtD
Rescinnamine—Headache—Erlotinib—kidney cancer	0.000196	0.0012	CcSEcCtD
Rescinnamine—Constipation—Vincristine—kidney cancer	0.000196	0.0012	CcSEcCtD
Rescinnamine—Pain—Vincristine—kidney cancer	0.000196	0.0012	CcSEcCtD
Rescinnamine—Paraesthesia—Gemcitabine—kidney cancer	0.000195	0.0012	CcSEcCtD
Rescinnamine—Cough—Paclitaxel—kidney cancer	0.000195	0.00119	CcSEcCtD
Rescinnamine—Nausea—Vinblastine—kidney cancer	0.000194	0.00119	CcSEcCtD
Rescinnamine—Nausea—Everolimus—kidney cancer	0.000193	0.00118	CcSEcCtD
Rescinnamine—Hypertension—Paclitaxel—kidney cancer	0.000193	0.00118	CcSEcCtD
Rescinnamine—Pruritus—Sunitinib—kidney cancer	0.000192	0.00118	CcSEcCtD
Rescinnamine—Myalgia—Paclitaxel—kidney cancer	0.00019	0.00117	CcSEcCtD
Rescinnamine—Hypersensitivity—Dactinomycin—kidney cancer	0.000189	0.00116	CcSEcCtD
Rescinnamine—Discomfort—Paclitaxel—kidney cancer	0.000188	0.00115	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Vincristine—kidney cancer	0.000188	0.00115	CcSEcCtD
Rescinnamine—Dizziness—Sorafenib—kidney cancer	0.000186	0.00114	CcSEcCtD
Rescinnamine—Pain—Gemcitabine—kidney cancer	0.000186	0.00114	CcSEcCtD
Rescinnamine—Constipation—Gemcitabine—kidney cancer	0.000186	0.00114	CcSEcCtD
Rescinnamine—Nausea—Erlotinib—kidney cancer	0.000186	0.00114	CcSEcCtD
Rescinnamine—Erythema—Capecitabine—kidney cancer	0.000183	0.00112	CcSEcCtD
Rescinnamine—Oedema—Paclitaxel—kidney cancer	0.000182	0.00112	CcSEcCtD
Rescinnamine—Abdominal pain—Vincristine—kidney cancer	0.000181	0.00111	CcSEcCtD
Rescinnamine—Infection—Paclitaxel—kidney cancer	0.000181	0.00111	CcSEcCtD
Rescinnamine—Dysgeusia—Capecitabine—kidney cancer	0.000179	0.0011	CcSEcCtD
Rescinnamine—Dizziness—Sunitinib—kidney cancer	0.000179	0.0011	CcSEcCtD
Rescinnamine—Rash—Sorafenib—kidney cancer	0.000178	0.00109	CcSEcCtD
Rescinnamine—Dermatitis—Sorafenib—kidney cancer	0.000178	0.00109	CcSEcCtD
Rescinnamine—Back pain—Capecitabine—kidney cancer	0.000177	0.00109	CcSEcCtD
Rescinnamine—Headache—Sorafenib—kidney cancer	0.000177	0.00108	CcSEcCtD
Rescinnamine—Gastritis—Doxorubicin—kidney cancer	0.000174	0.00106	CcSEcCtD
Rescinnamine—Rash—Sunitinib—kidney cancer	0.000171	0.00105	CcSEcCtD
Rescinnamine—Dermatitis—Sunitinib—kidney cancer	0.000171	0.00105	CcSEcCtD
Rescinnamine—Headache—Sunitinib—kidney cancer	0.00017	0.00104	CcSEcCtD
Rescinnamine—Influenza—Doxorubicin—kidney cancer	0.00017	0.00104	CcSEcCtD
Rescinnamine—Hypersensitivity—Vincristine—kidney cancer	0.000169	0.00104	CcSEcCtD
Rescinnamine—Nausea—Sorafenib—kidney cancer	0.000167	0.00103	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000166	0.00102	CcSEcCtD
Rescinnamine—Angina pectoris—Doxorubicin—kidney cancer	0.000165	0.00101	CcSEcCtD
Rescinnamine—Insomnia—Paclitaxel—kidney cancer	0.000165	0.00101	CcSEcCtD
Rescinnamine—Paraesthesia—Paclitaxel—kidney cancer	0.000164	0.001	CcSEcCtD
Rescinnamine—Bronchitis—Doxorubicin—kidney cancer	0.000163	0.000999	CcSEcCtD
Rescinnamine—Rash—Dactinomycin—kidney cancer	0.000162	0.000992	CcSEcCtD
Rescinnamine—Nausea—Sunitinib—kidney cancer	0.000161	0.000988	CcSEcCtD
Rescinnamine—Cough—Capecitabine—kidney cancer	0.00016	0.00098	CcSEcCtD
Rescinnamine—Hypertension—Capecitabine—kidney cancer	0.000158	0.00097	CcSEcCtD
Rescinnamine—Myalgia—Capecitabine—kidney cancer	0.000156	0.000956	CcSEcCtD
Rescinnamine—Pain—Paclitaxel—kidney cancer	0.000156	0.000955	CcSEcCtD
Rescinnamine—Constipation—Paclitaxel—kidney cancer	0.000156	0.000955	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000155	0.000948	CcSEcCtD
Rescinnamine—Discomfort—Capecitabine—kidney cancer	0.000154	0.000945	CcSEcCtD
Rescinnamine—Pruritus—Gemcitabine—kidney cancer	0.000154	0.000944	CcSEcCtD
Rescinnamine—Nausea—Dactinomycin—kidney cancer	0.000153	0.000935	CcSEcCtD
Rescinnamine—Dizziness—Vincristine—kidney cancer	0.000152	0.00093	CcSEcCtD
Rescinnamine—Oedema—Capecitabine—kidney cancer	0.00015	0.000917	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000149	0.000913	CcSEcCtD
Rescinnamine—Infection—Capecitabine—kidney cancer	0.000149	0.000911	CcSEcCtD
Rescinnamine—Urinary tract infection—Doxorubicin—kidney cancer	0.000147	0.0009	CcSEcCtD
Rescinnamine—Conjunctivitis—Doxorubicin—kidney cancer	0.000147	0.0009	CcSEcCtD
Rescinnamine—Urticaria—Paclitaxel—kidney cancer	0.000145	0.000887	CcSEcCtD
Rescinnamine—Rash—Vincristine—kidney cancer	0.000145	0.000887	CcSEcCtD
Rescinnamine—Dermatitis—Vincristine—kidney cancer	0.000145	0.000886	CcSEcCtD
Rescinnamine—Abdominal pain—Paclitaxel—kidney cancer	0.000144	0.000883	CcSEcCtD
Rescinnamine—Headache—Vincristine—kidney cancer	0.000144	0.000881	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—MME—kidney cancer	0.000143	0.049	CbGpPWpGaD
Rescinnamine—Sinusitis—Doxorubicin—kidney cancer	0.000142	0.000869	CcSEcCtD
Rescinnamine—Rash—Gemcitabine—kidney cancer	0.000137	0.000841	CcSEcCtD
Rescinnamine—Dermatitis—Gemcitabine—kidney cancer	0.000137	0.00084	CcSEcCtD
Rescinnamine—Headache—Gemcitabine—kidney cancer	0.000136	0.000836	CcSEcCtD
Rescinnamine—Nausea—Vincristine—kidney cancer	0.000136	0.000835	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000136	0.000835	CcSEcCtD
Rescinnamine—Rhinitis—Doxorubicin—kidney cancer	0.000136	0.000834	CcSEcCtD
Rescinnamine—Insomnia—Capecitabine—kidney cancer	0.000135	0.000829	CcSEcCtD
Rescinnamine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000135	0.000827	CcSEcCtD
Rescinnamine—Pharyngitis—Doxorubicin—kidney cancer	0.000135	0.000825	CcSEcCtD
Rescinnamine—Paraesthesia—Capecitabine—kidney cancer	0.000134	0.000823	CcSEcCtD
Rescinnamine—Hypersensitivity—Paclitaxel—kidney cancer	0.000134	0.000823	CcSEcCtD
Rescinnamine—Nausea—Gemcitabine—kidney cancer	0.000129	0.000792	CcSEcCtD
Rescinnamine—Pruritus—Paclitaxel—kidney cancer	0.000129	0.00079	CcSEcCtD
Rescinnamine—Pain—Capecitabine—kidney cancer	0.000128	0.000784	CcSEcCtD
Rescinnamine—Constipation—Capecitabine—kidney cancer	0.000128	0.000784	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000122	0.00075	CcSEcCtD
Rescinnamine—Dizziness—Paclitaxel—kidney cancer	0.000121	0.000739	CcSEcCtD
Rescinnamine—Urticaria—Capecitabine—kidney cancer	0.000119	0.000728	CcSEcCtD
Rescinnamine—Abdominal pain—Capecitabine—kidney cancer	0.000118	0.000725	CcSEcCtD
Rescinnamine—Erythema—Doxorubicin—kidney cancer	0.000118	0.000724	CcSEcCtD
Rescinnamine—Dysgeusia—Doxorubicin—kidney cancer	0.000116	0.000709	CcSEcCtD
Rescinnamine—Rash—Paclitaxel—kidney cancer	0.000115	0.000704	CcSEcCtD
Rescinnamine—Dermatitis—Paclitaxel—kidney cancer	0.000115	0.000704	CcSEcCtD
Rescinnamine—Back pain—Doxorubicin—kidney cancer	0.000114	0.0007	CcSEcCtD
Rescinnamine—Headache—Paclitaxel—kidney cancer	0.000114	0.0007	CcSEcCtD
Rescinnamine—Hypersensitivity—Capecitabine—kidney cancer	0.00011	0.000675	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—ACHE—kidney cancer	0.000109	0.0376	CbGpPWpGaD
Rescinnamine—Nausea—Paclitaxel—kidney cancer	0.000108	0.000663	CcSEcCtD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000106	0.0364	CbGpPWpGaD
Rescinnamine—Pruritus—Capecitabine—kidney cancer	0.000106	0.000648	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—PAX6—kidney cancer	0.000104	0.0357	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—CTSD—kidney cancer	0.000104	0.0356	CbGpPWpGaD
Rescinnamine—Cough—Doxorubicin—kidney cancer	0.000103	0.000632	CcSEcCtD
Rescinnamine—Hypertension—Doxorubicin—kidney cancer	0.000102	0.000625	CcSEcCtD
Rescinnamine—Myalgia—Doxorubicin—kidney cancer	0.000101	0.000616	CcSEcCtD
Rescinnamine—Discomfort—Doxorubicin—kidney cancer	9.94e-05	0.000609	CcSEcCtD
Rescinnamine—Dizziness—Capecitabine—kidney cancer	9.89e-05	0.000606	CcSEcCtD
Rescinnamine—Oedema—Doxorubicin—kidney cancer	9.64e-05	0.000591	CcSEcCtD
Rescinnamine—Infection—Doxorubicin—kidney cancer	9.58e-05	0.000587	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—BCHE—kidney cancer	9.53e-05	0.0327	CbGpPWpGaD
Rescinnamine—Rash—Capecitabine—kidney cancer	9.43e-05	0.000578	CcSEcCtD
Rescinnamine—Dermatitis—Capecitabine—kidney cancer	9.42e-05	0.000577	CcSEcCtD
Rescinnamine—Headache—Capecitabine—kidney cancer	9.37e-05	0.000574	CcSEcCtD
Rescinnamine—Nausea—Capecitabine—kidney cancer	8.88e-05	0.000544	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	8.78e-05	0.000538	CcSEcCtD
Rescinnamine—Insomnia—Doxorubicin—kidney cancer	8.72e-05	0.000534	CcSEcCtD
Rescinnamine—Paraesthesia—Doxorubicin—kidney cancer	8.66e-05	0.000531	CcSEcCtD
Rescinnamine—Pain—Doxorubicin—kidney cancer	8.24e-05	0.000505	CcSEcCtD
Rescinnamine—Constipation—Doxorubicin—kidney cancer	8.24e-05	0.000505	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Doxorubicin—kidney cancer	7.88e-05	0.000483	CcSEcCtD
Rescinnamine—Urticaria—Doxorubicin—kidney cancer	7.66e-05	0.000469	CcSEcCtD
Rescinnamine—Abdominal pain—Doxorubicin—kidney cancer	7.62e-05	0.000467	CcSEcCtD
Rescinnamine—Hypersensitivity—Doxorubicin—kidney cancer	7.1e-05	0.000435	CcSEcCtD
Rescinnamine—Pruritus—Doxorubicin—kidney cancer	6.82e-05	0.000418	CcSEcCtD
Rescinnamine—Dizziness—Doxorubicin—kidney cancer	6.38e-05	0.000391	CcSEcCtD
Rescinnamine—Rash—Doxorubicin—kidney cancer	6.08e-05	0.000373	CcSEcCtD
Rescinnamine—Dermatitis—Doxorubicin—kidney cancer	6.07e-05	0.000372	CcSEcCtD
Rescinnamine—Headache—Doxorubicin—kidney cancer	6.04e-05	0.00037	CcSEcCtD
Rescinnamine—Nausea—Doxorubicin—kidney cancer	5.73e-05	0.000351	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—EIF5B—kidney cancer	5.45e-05	0.0187	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—POMC—kidney cancer	4.92e-05	0.0169	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CUL7—kidney cancer	4.86e-05	0.0167	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	4.82e-05	0.0166	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—HSPA9—kidney cancer	4.64e-05	0.0159	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—RYR1—kidney cancer	4.27e-05	0.0147	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—MUC4—kidney cancer	3.78e-05	0.013	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNMA1—kidney cancer	3.78e-05	0.013	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—ACHE—kidney cancer	3.65e-05	0.0125	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ST3GAL2—kidney cancer	3.6e-05	0.0123	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—CTNNB1—kidney cancer	3.51e-05	0.0121	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—EEF2—kidney cancer	3.51e-05	0.0121	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—BCHE—kidney cancer	3.18e-05	0.0109	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—ACHE—kidney cancer	2.79e-05	0.00959	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—MME—kidney cancer	2.69e-05	0.00925	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	2.54e-05	0.00873	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—HSPD1—kidney cancer	2.5e-05	0.0086	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—RPL14—kidney cancer	2.5e-05	0.0086	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	2.46e-05	0.00844	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	2.45e-05	0.00842	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	2.45e-05	0.00842	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	2.45e-05	0.00842	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—BCHE—kidney cancer	2.43e-05	0.00836	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ACHE—kidney cancer	2.07e-05	0.00709	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—EIF4EBP1—kidney cancer	2.04e-05	0.00701	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—PAX6—kidney cancer	1.97e-05	0.00675	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CTSD—kidney cancer	1.95e-05	0.00671	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—BCHE—kidney cancer	1.8e-05	0.00618	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—BRAF—kidney cancer	1.62e-05	0.00557	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—IGF2—kidney cancer	1.39e-05	0.00478	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—RAF1—kidney cancer	1.35e-05	0.00465	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.29e-05	0.00444	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.25e-05	0.00429	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—BRAF—kidney cancer	1.24e-05	0.00427	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—RAF1—kidney cancer	1.04e-05	0.00356	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	9.85e-06	0.00338	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—POMC—kidney cancer	9.3e-06	0.00319	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—MAPK1—kidney cancer	9.28e-06	0.00319	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—MAPK1—kidney cancer	7.11e-06	0.00244	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CTNNB1—kidney cancer	6.64e-06	0.00228	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—RAF1—kidney cancer	5.57e-06	0.00191	CbGpPWpGaD
